Why is the latex test avoided in the Classification Criteria for Rheumatoid Arthritis (CASPAR) criteria for diagnosing rheumatoid arthritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 7, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Why Latex Test is Avoided in CASPAR Criteria

The latex test is not avoided in CASPAR criteria—CASPAR is for psoriatic arthritis, not rheumatoid arthritis, and includes "rheumatoid factor negativity" as one of its diagnostic features, which can be assessed using latex or other RF testing methods. 1

Clarification of the Question

There appears to be confusion in the question. CASPAR (ClASsification criteria for Psoriatic ARthritis) is used to diagnose psoriatic arthritis, not rheumatoid arthritis. 1

CASPAR Criteria Components

The CASPAR criteria require established inflammatory articular disease (tender/swollen joints with prolonged morning stiffness) plus at least 3 points from these features: 1

  • Current psoriasis (2 points)
  • Personal history of psoriasis (1 point, unless current psoriasis present)
  • Family history of psoriasis (1 point, unless current psoriasis or personal history present)
  • Current dactylitis or history of dactylitis (1 point)
  • Juxta-articular new bone formation on radiographs (1 point)
  • Rheumatoid factor negativity (1 point)
  • Typical psoriatic nail dystrophy including onycholysis, pitting, and hyperkeratosis (1 point)

Why RF Negativity Matters in CASPAR

Rheumatoid factor negativity is included in CASPAR criteria to help differentiate psoriatic arthritis from rheumatoid arthritis, not to avoid the latex test itself. 1

Distinguishing PsA from RA

  • Patients with peripheral polyarticular psoriatic arthritis may share several features with RA, making differentiation challenging 1
  • The presence of rheumatoid factor helps distinguish seronegative RA with coincidental psoriasis from true psoriatic arthritis 1
  • Patients displaying characteristic signs of RA (rheumatoid nodules, extra-articular involvement, high RF titers) should not receive a PsA diagnosis 1
  • Approximately 20% of PsA patients, especially females, have symmetric polyarticular inflammatory arthritis resembling RA, differentiated by cutaneous or nail findings 1

Latex Test Performance Characteristics

If RF testing is performed for CASPAR criteria, the latex fixation test is actually highly specific and reliable, contrary to older beliefs: 2

  • Latex fixation testing demonstrates sensitivity of 81.6% at 1:20 titer and 78.0% at 1:80 titer for RA 2
  • Specificity against non-inflammatory rheumatic disorders is 96.6% at 1:20 and 97.9% at 1:80 2
  • The predictive value of a positive latex test at 16.4% RA prevalence is approximately 80% 2
  • Latex testing is far more specific than historically believed, and titers do not spuriously increase with age 2

Alternative RF Testing Methods

While latex is acceptable, other methods can be used to assess RF status: 3, 4

  • ELISA for IgM RF is a reasonable alternative to latex fixation when age and gender are considered 4
  • Nephelometry shows good correlation with ELISA methods 3
  • ELISA demonstrates greater sensitivity and can measure IgG RF and IgA RF in addition to IgM RF 3
  • Both latex and ELISA methods are reliable, accurate, rapid, and sensitive for routine clinical purposes 3

Clinical Pitfall to Avoid

Do not confuse CASPAR criteria (for psoriatic arthritis) with ACR/EULAR criteria (for rheumatoid arthritis). The CASPAR criteria have 98.7% specificity and 91.4% sensitivity for diagnosing psoriatic arthritis, not rheumatoid arthritis. 1

Related Questions

What is the most likely diagnosis for an elderly female with right hand swelling, joint pain in the metacarpophalangeal joints (MCPs), and an elevated rheumatoid factor (RF) level of 29?
What is the best management approach for a 61-year-old female with chronic inflammatory arthritis, bilateral ankle and toe deformities, and recent onset of hyperkeratosis, with lab results showing elevated RF (Rheumatoid Factor) and normal ESR (Erythrocyte Sedimentation Rate), awaiting anti-CCP (Cyclic Citrullinated Peptide) and HLA B27 results?
What is the likely diagnosis and management plan for a 61-year-old female with progressive foot pain, plantar pain, and bilateral ankle and toe deformities, with a slightly elevated ESR and normal renal function?
What is the diagnosis and treatment for a 61-year-old female with foot pain, plantar pain, bilateral ankle deformity, toe deformities, nail dystrophy, and backache, with lab results showing slightly elevated Erythrocyte Sedimentation Rate (ESR) and normal vitamin B12 level?
What could be causing an elderly patient with a history of rheumatoid arthritis (RA) to experience mild paresthesias in her bilateral hands/fingers, particularly when urinating?
Is it safe for a patient with erectile dysfunction, currently taking sildenafil (25mg daily as needed), to increase their dosage, and what monitoring is required?
What is the cause of a patient's episodes of syncope, vomiting, and diarrhea after consuming meat, specifically steak or pork, at night?
What is the recommended dosing of olmesartan (angiotensin II receptor antagonist) for a typical adult patient with hypertension, considering factors such as renal function and potential hyperkalemia?
What is the appropriate workup for a patient presenting with fatigue and hypophosphatemia?
Should a 65-year-old male with a Prostate-Specific Antigen (PSA) level of 2.1, which has increased from 1.7 over the past 12 months, undergo a prostate biopsy?
Is Relugolix (gonadotropin-releasing hormone receptor antagonist) associated with adrenal insufficiency in adult males with hormone-sensitive prostate cancer, particularly those with a history of steroid use or adrenal gland dysfunction?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.